These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 21874883)

  • 21. Fertility preserving surgical treatment of borderline ovarian tumour: long-term consequence for fertility and recurrence.
    Marcickiewicz J; Brännström M
    Acta Obstet Gynecol Scand; 2006; 85(12):1496-500. PubMed ID: 17260228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Results of fertility preserving operations in malignant ovarian tumors].
    Kleine W
    Zentralbl Gynakol; 1996; 118(6):317-21. PubMed ID: 8768006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recurrence after cystectomy for borderline ovarian tumors: results of a French multicenter study.
    Poncelet C; Fauvet R; Boccara J; Daraï E
    Ann Surg Oncol; 2006 Apr; 13(4):565-71. PubMed ID: 16491337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pseudomyxoma peritonei: a review of 23 cases.
    Wertheim I; Fleischhacker D; McLachlin CM; Rice LW; Berkowitz RS; Goff BA
    Obstet Gynecol; 1994 Jul; 84(1):17-21. PubMed ID: 8008316
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complete lymph node dissection: is it essential for the treatment of borderline epithelial ovarian tumors?
    Kanat-Pektas M; Ozat M; Gungor T; Sahin I; Yalcin H; Ozdal B
    Arch Gynecol Obstet; 2011 Apr; 283(4):879-84. PubMed ID: 20549509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experimental characterization of recurrent ovarian immature teratoma cells after optimal surgery.
    Tanaka T; Toujima S; Utsunomiya T; Yukawa K; Umesaki N
    Oncol Rep; 2008 Jul; 20(1):13-23. PubMed ID: 18575713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Constitutive characteristics and change trend of gynecological malignant tumors in 8009 hospitalized patients in Guangxi Zhuang Autonomous Region].
    Huang W; Li L; Yu DQ; Huang YL; Liu Y; Chen XQ; Tang BJ; Xu H; Ma G; Dong LH; Li L; Qiu Y; Bai H; Nong WZ; Li L; Zeng DY; Jiang FY; Lan Y; Ye Y; Tang XZ; Wang DX; Li HZ; Pan YB; Mo AX; Wu XY; Lei ZY; Zhou GP; Liu C; Su QH
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jan; 42(1):22-5. PubMed ID: 17331416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surgery of borderline tumors of the ovary: retrospective comparison of short-term outcome after laparoscopy or laparotomy.
    Ødegaard E; Staff AC; Langebrekke A; Engh V; Onsrud M
    Acta Obstet Gynecol Scand; 2007; 86(5):620-6. PubMed ID: 17464594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Safety and effectiveness of endosurgical management of benign adnexal tumors in the premenopausal period: a prospective study].
    Hesseling M; De Wilde RL
    Geburtshilfe Frauenheilkd; 1994 Aug; 54(8):437-9. PubMed ID: 7982546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular analysis of an immature ovarian teratoma with gliomatosis peritonei and recurrence suggests genetic independence of multiple tumors.
    Best DH; Butz GM; Moller K; Coleman WB; Thomas DB
    Int J Oncol; 2004 Jul; 25(1):17-25. PubMed ID: 15201985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical significance of the tumor marker CA-125 for the preoperative diagnosis and postoperative management of patients with malignant ovarian cancers].
    Sevelda P; Salzer H; Dittrich C; Spona J
    Geburtshilfe Frauenheilkd; 1985 Nov; 45(11):769-73. PubMed ID: 3865860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histological pattern of ovarian tumors and their age distribution.
    Jha R; Karki S
    Nepal Med Coll J; 2008 Jun; 10(2):81-5. PubMed ID: 18828427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Epithelial ovarian tumors in adolescence: a study of clinical features and treatment].
    Li M; Pan LY; Huang HF; Lang JH
    Zhonghua Fu Chan Ke Za Zhi; 2004 Sep; 39(9):598-601. PubMed ID: 15498186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Our experience in treating ovarian tumors with borderline malignancy].
    Ivanov S; Kŭrlov T; Ivanov S
    Akush Ginekol (Sofiia); 2000; 39(1):39-41. PubMed ID: 10826337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Recurrent mature ovarian teratomas: retrospective analysis of 20 cases].
    Song YN; Zhu L; Lang JH
    Zhonghua Yi Xue Za Zhi; 2007 May; 87(17):1184-6. PubMed ID: 17686238
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surgery for ovarian masses in infants, children, and adolescents: 102 consecutive patients treated in a 15-year period.
    Cass DL; Hawkins E; Brandt ML; Chintagumpala M; Bloss RS; Milewicz AL; Minifee PK; Wesson DE; Nuchtern JG
    J Pediatr Surg; 2001 May; 36(5):693-9. PubMed ID: 11329568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complete salvage surgical cytoreduction improves further survival of patients with late recurrent ovarian cancer.
    Gadducci A; Iacconi P; Cosio S; Fanucchi A; Cristofani R; Riccardo Genazzani A
    Gynecol Oncol; 2000 Dec; 79(3):344-9. PubMed ID: 11104603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Borderline ovarian tumors. Retrospective analysis of 20 cases].
    Iervolino P; Palmieri M; Rotondi M; D'Alessandro P; Iuliano R
    Minerva Ginecol; 2001 Feb; 53(1 Suppl 1):97-9. PubMed ID: 11526732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary ovarian carcinoid tumors.
    Davis KP; Hartmann LK; Keeney GL; Shapiro H
    Gynecol Oncol; 1996 May; 61(2):259-65. PubMed ID: 8626144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prognostic factors and reproductive outcomes of borderline ovarian tumors: a review of 186 patients].
    Tao T; Cao DY; Yang JX; Huang HF; Wu M; Pan LY; Lang JH; Guo LN; Shen K
    Zhonghua Yi Xue Za Zhi; 2010 May; 90(19):1304-8. PubMed ID: 20646576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.